[0 -> 10] Hello, ladies and gentlemen. Thank you for standing by for the second quarter 2023 earnings [10 -> 17] conference call for Xpeng Inc. At this time, all participants are in listen-only mode. [17 -> 22] After management's remarks, there will be a question and answer session. Today's conference [22 -> 27] call is being recorded. I will now turn the call over to your host, Mr. Alex Yeh, Head [27 -> 32] of Investor Relations for the company. Please go ahead, Alex. [32 -> 37] Thank you. Hello, everyone, ...

Financial Data and Key Metrics Changes - In the first half of 2023, the company faced significant challenges, including a tax impact of approximately 60 million, primarily due to prior losses in some subsidiaries that may not be recoverable [1][2] - The overall mobile game industry saw a year-on-year decline of 3.41%, with actual sales revenue slightly over 100 billion [1][3] - Sales and R&D expenses were aligned with revenue, with a notable decrease in sales expenses during the first half of the year [1][2] Business Line Data and Key Metrics Changes - The company reported a stable performance from existing products, with top sellers including "Fusheng Wenqing Ge" and "Lin Nuo" maintaining positions in the top 100 sales charts [1][3] - The new product "Fusheng Yiling Long" is progressing well, with a month-long paid testing phase yielding satisfactory data [1][2] Market Data and Key Metrics Changes - The overall market environment has been challenging, with a general decline in consumer spending and changes in traffic patterns affecting revenue [1][3] - The company is exploring the mini-game segment and casual gaming, recognizing the potential for growth in these areas [1][2] Company Strategy and Development Direction - The company aims to enhance project management and cost control, with a focus on product innovation over the next three years [1][2] - There is a commitment to exploring AI applications in game development, which is expected to improve efficiency and reduce costs [1][3] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that 2023 is a challenging year but expressed confidence in a positive outlook for the second half, driven by stable performance from existing products and careful management of new launches [1][2] - The company is optimistic about the potential for a turnaround in 2024, contingent on the success of new product launches and market conditions [1][3] Other Important Information - The company is actively pursuing overseas market opportunities, with a focus on customized products for international players [1][2] - There is an ongoing effort to optimize internal processes and enhance the quality of game offerings [1][3] Q&A Session Summary Question: What are the characteristics of "Fusheng Yiling Long" compared to similar products in the market? - The product features significant innovations in gameplay and exploration, with positive player feedback on its unique mechanics and artistic design [1][2] Question: What is the company's strategy regarding mini-games and casual gaming? - The company is monitoring the mini-game segment and has ongoing research and development efforts in this area, aiming to capitalize on emerging trends [1][3] Question: Can the company share any results from AI applications in game development? - AI has been integrated into various projects, leading to reduced development times and cost savings, with ongoing testing of new functionalities [1][2] Question: What is the outlook for the company's performance in 2023? - Management expects a positive trend in the second half of the year, with stable performance from existing products and careful management of new launches [1][3] Question: How is the company addressing the challenges faced in recent years? - The company is enhancing project management standards, adapting to market changes, and focusing on innovation in both gameplay and technology [1][2]

[0 -> 15] Good day and welcome to Bilibili Second Quarter 2023 Financial Results and Business Update [15 -> 20] conference call. Today's conference is being recorded. At this time, I would like to turn [20 -> 26] the conference over to Juliet Yang, Executive Director of Investor Relations. Please go [26 -> 36] ahead. Thank you, operator. During this call, we'll [36 -> 42] discuss business outlook and make forward-looking statements. These comments are based on our [42 -> 49] predictions and expectations as ...

接下来我很荣幸的向大家介绍出席本次业绩发布会的管理层他们是主席闫明炽先生大家好董事总经理方海舟先生大家好副董事总经理闫贤龙先生大家好首席财务总监邱丽文女士Hello 刚才主持人也介绍了一下益胜的基本情况我在这里再强调一下其实益胜是作为一家生物科技企业我们是拥有先进的和成熟的产品以及有很好的经营性先进比例 还有也拥有全流程的生物原料制剂的生产平台涵盖向低盐液 沿用凝胶 外用凝胶 液体制剂 动钢制剂等也有一系列吹逛风的单气炼平台 也成为了一家口腔科后面一系列的产品在新加坡的独家销售代理同时我们也发布了一项在家用官僚治疗高端品牌叫佩特 那么这个应该是充分的利用了医生在眼科跟外科这些优势我们是不断的获取产品来提高我们的收入跟利润医生的核心业务其实大家刚才也介绍过主要是有眼科和外科两个部分组成那么眼科的这个业务其实现在应该说是已经涵盖了我们从眼表 那么这个就是现在应该说艺术已经基本上打造起一个完整的这个眼科的产品组合那在这在大家在器械方面我们也含有一系列在这个像钢眼的器械还在布置之中对那么眼科的产品大家最突出的就是我们的背弧术系列那背弧术系列呢应该说经过了不断的 那么可见他的在目前的知名度和美意度以及临床的认可度也是非 ...

[0 -> 5] Relations at Lenovo. Thanks everyone for joining us. Before we start, let me introduce our [5 -> 11] management team joining the call today. Mr. Yang Yuanqing, Lenovo's Chairman and CEO. [12 -> 18] Mr. Wang Yiming, Group CFO. Mr. Ken Wong, President of Solutions and Services Group. [19 -> 25] Mr. Chris Galgen, President of Infrastructure Solutions Group. Mr. Luca Rossi, President [25 -> 31] of Intelligent Devices Group. We will begin with Ernie's presentations and shortly after that, [31 -> 36] we ...

[0 -> 5] Relations at Lenovo. Thanks everyone for joining us. Before we start, let me introduce our [5 -> 11] management team joining the call today. Mr. Yang Yuanqing, Lenovo's Chairman and CEO. [12 -> 18] Mr. Wang Yiming, Group CFO. Mr. Ken Wong, President of Solutions and Services Group. [19 -> 25] Mr. Chris Galgen, President of Infrastructure Solutions Group. Mr. Luca Rossi, President [25 -> 31] of Intelligent Devices Group. We will begin with Ernie's presentations and shortly after that, [31 -> 36] we ...

[3 -> 32] 下午好,女士們先生們我謹代表新鴻基有限公司歡迎各位出席公司2023年創辦人業績投資者晚上會議本次會議將以普通話進行各位投資者的麥克風設置為靜音演講結束後將有問答環節現在我為大家介紹今天公司的管理層集團投資者關係副總裁張前女士Shirley [33 -> 62] 在今天的会议上宣理将会向各位投资者介绍公司2023年上半年业绩表现以及下半年的展望和发展计划简解结束后宣理将回答各位的问题今天的讨论包括前瞻性陈述并涉及集团无法控制的假设和因素相关的陈述不一定代表集团未来的表现也不构成跟未来表现的保证 [63 -> 91] 首先我们有请Sherry为大家讲讲业绩好的,谢谢各位投资者,大家下午好首先看一下我们主要的核心业务分布我们的核心业务围绕三大板块展开包括融资、投资管理和基金管理业务我们通过亚洲联合财务西红柿信贷和私募融资开展贷款业务为我们提供稳定和具有韧性的资金流 [92 -> 118] 我們的投資管理業務充分利用集團的業務專長外部的關係網絡和雄厚的資本實力在多元化的資產類別、行業和地區中尋找具有吸引力的風險調整回報我們的基金管理業務持有管理外部資本的監管牌照包括通過新推出的家族辦公室解決方案和 ...

[3 -> 11] Good day and good evening. Thank you for standing by. Welcome to Tencent Holdings Limited 2023 [11 -> 17] Second Quarter Results Announcement Webinar. I'm Wendy Huang from Tencent's IR team. At [17 -> 23] this time, all participants are in a listen-only mode. After the management's presentation, [23 -> 28] there will be a question and answer session. For participants who are dialing by phone, [28 -> 34] if you wish to ask a question, please press 5 on your telephone to raise your hand. If [34 -> 3 ...

[1 -> 29] 各位投资人、分析师,大家上午好欢迎各位参加药师帮股份有限公司2023年中期业绩交流会公司已于8月15日发布了2023年中期业绩报告为让资本市场更加及时和全面了解公司中期业绩的具体情况公司开展此次交流会与大家做一个专题性的交流 [31 -> 58] 药师邦股份有限公司是中国领先的院外数字化医药产业综合服务平台公司于2023年6月28日在港交所主板挂牌上市药师邦通过数字化解决方案链接医药产业链上下游为医药价值链上的参与者建立了安全高效的交易及服务平台 [59 -> 83] 公司以让好医好药普惠可及为使命驱动医药价值产业链整体向高效率和高质量发展本次出席会议的管理层有公司董事会主席兼首席执行官张步震先生公司执行董事兼首席财务官陈飞先生 [85 -> 114] 今天的业绩交流会将分为两个部分会议全程预计一个小时第一部分请公司管理层为大家介绍2023年中期业绩相关情况此环节预计时长30到40分钟第二部分为问答环节投资人可与管理层进行提问交流下面有请公司管理层为大家介绍公司的中期业绩情况 [116 -> 142] 好感谢大家来参加我们钥匙邦2023年上半年的业绩发布会这是我们上市后的第一次业绩发布会我 ...

感谢大家参加本次会议,会议即将开始,请稍后。感谢大家参加本次会议,会议即将开始,请稍后。 这次会议是中国国际资产合作组织CICC的闭门会议只有邀请客人可以参加不需要CICC和评论员签署的允许任何组织或人员不得删除、翻载、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、複制、� 潜在的Basin-class CSF1-R1-Z ABS-K021获得了FDA CBE以及EMA在内的这个Breakthrough的多项认证或者是这个优先药物资格那用于TBCP的国际三期临床也完成了中美首例患者的给药另外呢公司的FGFR41-Z与口服的PDR11-Z临床数据也将在接下来的ISMO会议上有更新的临床进展 临床比例方面都取得了稳步的推进另外财务状况也是非常稳健OK 首先介绍一下中晚期的临床管线第一个我要讲的是我们的ABS-K021 Pimicotinib这个项目获得了中美欧三级突破性疗法的认定 在早期管轻方面我们有新一代的EGFR-X20移植剂已经获得了美国FDA和MDP的批件这是针对肺癌的疫情实验马上就会进行A ...